Does Insulin Resistance Cause Weight Gain?
Insulin resistance and weight gain are closely linked, with each condition capable of worsening the other. When cells stop responding properly to insulin, the pancreas produces more of it, and elevated insulin levels promote fat storage, particularly around the abdomen. Understanding whether insulin resistance causes weight gain, and how to break this cycle, is important for anyone struggling with unexplained weight changes, prediabetes, PCOS, or type 2 diabetes. This article explains the mechanisms involved, the signs to look out for, and what NHS and NICE guidance recommends for treatment and lifestyle change.
Summary: Insulin resistance contributes to weight gain by promoting fat storage through elevated insulin levels, and excess body fat in turn worsens insulin resistance, creating a self-reinforcing cycle.
- Insulin resistance causes the pancreas to overproduce insulin, a state called hyperinsulinaemia, which promotes fat storage, particularly visceral fat around the organs.
- The relationship is bidirectional: excess body fat worsens insulin resistance, and insulin resistance makes further weight gain more likely.
- Key clinical signs include central adiposity, fatigue after meals, acanthosis nigricans, raised fasting glucose, low HDL cholesterol, and elevated triglycerides.
- Losing 5 to 10 per cent of body weight can significantly improve insulin sensitivity, lower fasting insulin, and reduce blood glucose levels.
- NHS and NICE guidance recommends structured lifestyle intervention, including dietary change and at least 150 minutes of moderate aerobic activity per week, as the first-line approach.
- Pharmacological options such as metformin, tirzepatide (Mounjaro), and semaglutide (Wegovy) may be considered where lifestyle measures alone are insufficient, subject to individual clinical assessment.
| Factor | How it relates to insulin resistance and weight | Clinical relevance | Recommended action |
|---|---|---|---|
| Hyperinsulinaemia | Elevated insulin from compensatory pancreatic output promotes fat storage and central adiposity | Key driver of visceral fat accumulation and metabolic syndrome | Fasting insulin, fasting glucose and HbA1c testing via GP |
| Visceral fat | Releases inflammatory signals that further impair insulin signalling, worsening resistance | Waist circumference used alongside BMI in UK clinical risk assessment | Reduce visceral fat through dietary change and aerobic exercise |
| Diet and refined carbohydrates | High intake of free sugars and refined carbohydrates drives blood glucose fluctuation and fat storage | NHS Eatwell Guide and NICE guidance recommend reducing refined carbs and increasing fibre | Increase vegetables, legumes and wholegrains; reduce sugary drinks |
| Physical activity | Skeletal muscle is a major glucose uptake site; exercise improves insulin signalling independently of weight loss | UK Chief Medical Officers recommend at least 150 minutes moderate aerobic activity per week | Combine aerobic and resistance training on most days |
| Weight loss of 5 to 10 per cent | Reduces fasting insulin, lowers blood glucose and decreases inflammatory signals from visceral fat | NICE guidance on obesity management supports this as a meaningful metabolic target | Pursue sustainable calorie deficit; avoid short-term dieting that risks weight regain |
| Prediabetes and PCOS | Both conditions are closely associated with insulin resistance and make weight management more challenging | HbA1c 42 to 47 mmol/mol or fasting plasma glucose 6.1 to 6.9 mmol/l indicates non-diabetic hyperglycaemia | GP referral to NHS Diabetes Prevention Programme; specialist review for PCOS |
| Pharmacological options | Metformin, tirzepatide (Mounjaro) and semaglutide (Wegovy) may be considered where lifestyle measures are insufficient | MHRA-authorised options appraised by NICE; suitability requires individual medical assessment | Discuss eligibility with GP or ICB-commissioned specialist service |
Table of Contents
Does insulin resistance cause weight gain?
Insulin resistance promotes weight gain by raising insulin levels, which increases fat storage, particularly visceral fat; in turn, excess fat worsens insulin resistance, creating a bidirectional cycle.
Insulin resistance does contribute to weight gain, primarily by disrupting the body's ability to use glucose efficiently and by promoting fat storage. Insulin is a hormone produced by the pancreas that allows cells to absorb glucose from the bloodstream for energy. When cells become resistant to insulin's signals, the pancreas compensates by producing more insulin. These elevated insulin levels, a state known as hyperinsulinaemia, are associated with increased fat storage and are linked to central adiposity, though the precise mechanisms are multifactorial and continue to be studied.[2][3]
The relationship between insulin resistance and weight gain is bidirectional, meaning each condition can worsen the other. Excess body fat, especially visceral fat stored around the organs, releases inflammatory signals that further impair insulin signalling.[16][17] This creates a cycle in which weight gain worsens insulin resistance, and insulin resistance makes further weight gain more likely.
It is important to note that insulin resistance does not cause weight gain in isolation. Dietary habits, physical activity levels, sleep quality, stress hormones such as cortisol, and genetic factors all interact with insulin sensitivity. Insulin resistance is recognised as a significant metabolic driver of weight accumulation, particularly in people with prediabetes, polycystic ovary syndrome (PCOS), or type 2 diabetes. Addressing insulin resistance alongside creating a sustainable energy deficit is considered an important component of long-term weight management, as outlined in NICE guidance on obesity and type 2 diabetes prevention.
What are the signs that insulin resistance might be affecting your weight?
Key signs include difficulty losing weight, central adiposity, post-meal fatigue, cravings for sugary foods, acanthosis nigricans, raised fasting glucose, and low HDL cholesterol; a GP can investigate with fasting glucose and HbA1c tests.
Insulin resistance affecting weight often presents as persistent difficulty losing weight despite a reasonable diet and regular physical activity, alongside a tendency to gain weight around the abdomen rather than the hips or thighs. This pattern of central or visceral adiposity is one of the more recognisable clinical indicators and is relevant to metabolic risk assessment; waist circumference is used alongside BMI in UK clinical practice to assess this risk.
Other signs that may suggest insulin resistance include:
-
Fatigue after meals, particularly those high in refined carbohydrates or sugar
-
Cravings for sweet or starchy foods, which may reflect fluctuating blood glucose levels
-
Acanthosis nigricans, a darkening and thickening of the skin in folds such as the neck, armpits or groin, which is a recognised dermatological marker of hyperinsulinaemia[14][15]
-
Elevated fasting blood glucose or triglycerides on routine blood tests
-
Low HDL cholesterol (often called "good" cholesterol)
-
Raised blood pressure
These features, when clustered together, may indicate metabolic syndrome, a condition closely linked to insulin resistance.[6] Women with PCOS frequently experience insulin resistance as part of their condition, which can make weight management particularly challenging.
The symptoms listed above are non-specific and are not individually diagnostic of insulin resistance; they should be interpreted alongside clinical assessment and blood tests.
If you recognise several of these signs, it is worth discussing them with your GP. A fasting glucose test and HbA1c measurement are the standard investigations used in UK practice to identify non-diabetic hyperglycaemia (prediabetes). In UK practice, an HbA1c of 42 to 47 mmol/mol or a fasting plasma glucose of 6.1 to 6.9 mmol/l may indicate non-diabetic hyperglycaemia; your GP will advise on whether repeat testing or further investigation is needed. A fasting lipid profile can also help clarify metabolic risk. Early identification allows for timely lifestyle intervention before the condition progresses to type 2 diabetes.
If you experience symptoms that may suggest diabetes, such as increased thirst, passing urine more frequently than usual, unexplained weight loss, or recurrent infections, seek prompt medical advice rather than waiting for a routine appointment.
Can losing weight help reverse insulin resistance?
Yes, losing 5 to 10 per cent of body weight can meaningfully improve insulin sensitivity, reduce fasting insulin, and lower blood glucose, particularly when achieved through combined dietary change and physical activity.
Losing weight is one of the most effective ways to improve insulin sensitivity, and even modest reductions in body weight can produce meaningful metabolic benefits. Clinical evidence and NICE guidance on obesity management indicate that losing around 5 to 10 per cent of body weight can significantly reduce fasting insulin levels, lower blood glucose, and improve the body's response to insulin signalling.[2] This improvement occurs partly because reducing visceral fat decreases the inflammatory signals that interfere with insulin receptors in muscle, liver and fat tissue.
The approach to weight loss also matters. Fat loss achieved through a combination of dietary change and increased physical activity tends to produce greater improvements in insulin sensitivity than dietary change alone. This is because skeletal muscle is a major site of glucose uptake, and exercise independently improves insulin signalling in muscle cells, even before significant weight loss occurs.[19][20]
For people with more significant insulin resistance or obesity, lifestyle changes alone may not always be sufficient. In these cases, a GP or specialist may consider additional support. Structured weight management programmes, pharmacological options, or referral to a specialist service may all be appropriate depending on individual circumstances and local ICB commissioning pathways, in line with NICE guidance. Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online weight-management consultations, with prescriber review and pharmacist support, where clinically appropriate options may be considered alongside lifestyle guidance.
Prescription weight-management medicines are not suitable for everyone; they are not recommended during pregnancy or breastfeeding, and suitability requires individual medical assessment.
It is also worth noting that weight regain can reverse the metabolic gains achieved, which is why sustainable lifestyle change, rather than short-term dieting, is emphasised in clinical guidance. Maintaining even a modest reduction in body weight over the long term has been shown to preserve improvements in insulin sensitivity.
What treatments and lifestyle changes does the NHS recommend?
The NHS recommends dietary modification, at least 150 minutes of moderate aerobic activity per week, and structured programmes such as the NHS Diabetes Prevention Programme, with pharmacological options considered where lifestyle measures are insufficient.
The NHS recommends a combination of dietary modification, increased physical activity, and behavioural support as the foundation of managing insulin resistance and associated weight gain. NICE guidance on obesity and type 2 diabetes prevention consistently emphasises that structured lifestyle interventions are the first-line approach for people with insulin resistance or prediabetes.
Dietary recommendations broadly align with NHS Eatwell Guide principles and include:
-
Reducing intake of refined carbohydrates, sugary drinks and foods high in free sugars or saturated fat
-
Increasing dietary fibre through vegetables, legumes and wholegrains, which slow glucose absorption
-
Reducing overall calorie intake in a sustainable, non-restrictive way
Physical activity guidance from the UK Chief Medical Officers recommends at least 150 minutes of moderate-intensity aerobic activity per week, alongside muscle-strengthening activities on two or more days.[7][8] Both aerobic exercise and resistance training independently improve insulin sensitivity.[20][21]
For people with prediabetes, the NHS Diabetes Prevention Programme (NHS DPP) offers a structured, evidence-based group programme covering diet, physical activity and behaviour change. Referral is typically made through a GP following an HbA1c result of 42 to 47 mmol/mol or a fasting plasma glucose of 6.[1]1 to 6.9 mmol/l.
Where lifestyle measures are insufficient, pharmacological treatment may be considered. Metformin is sometimes used to improve insulin sensitivity in people with prediabetes or PCOS; NICE guidance on type 2 diabetes prevention indicates it may be considered in defined high-risk groups after lifestyle measures have been tried, and its use in PCOS is guided by specialist assessment given its off-label status in that context.[4][5] For people living with obesity and insulin resistance, NICE has also appraised newer weight-management medicines. Tirzepatide (Mounjaro) is authorised by the MHRA for both type 2 diabetes and chronic weight management in adults, and semaglutide (Wegovy) is similarly authorised for weight management. Other licensed options may also be considered in line with NICE appraisals and local ICB commissioning decisions. Your GP or an ICB-commissioned specialist service can advise on whether any pharmacological option is appropriate for your circumstances.
Scientific References
- Type 2 diabetes: prevention in people at high risk (PH38).
- Overweight and obesity management (NG246).
- Type 2 diabetes in adults: management (NG28).
- Polycystic ovary syndrome: metformin in women not planning pregnancy (ESUOM6) – key points.
- Polycystic ovary syndrome: metformin in women not planning pregnancy (ESUOM6) – full PDF.
- Metabolic syndrome.
- UK Chief Medical Officers' physical activity guidelines.
- Physical activity guidelines for adults aged 19 to 64.
- MHRA authorises diabetes drug Mounjaro (tirzepatide) for weight management and weight loss.
- Tirzepatide | Drugs | BNF – NICE.
- Tirzepatide | NHS medicines.
- MHRA approves GLP-1 receptor agonist semaglutide to reduce risk of serious heart problems in obese or overweight adults.
- Semaglutide | Drugs | BNF – NICE.
- Is Acanthosis Nigricans a Marker for Metabolic Syndrome? A Systematic Review.
- Review of facial acanthosis nigricans: Easy to diagnose and difficult to treat marker of hyperinsulinemia/metabolic syndrome.
- Nutrition, Circadian Regulation, and the Gut-Melatonin-Visceral Adipose Tissue Axis: An Integrative Narrative Review.
- NRF2 activation attenuates obesity-induced adipose inflammation by suppressing STING signaling, with depot-specific regulation.
- GNPAT-driven plasmalogen biosynthesis regulates macrophage polarization and protects against obesity-induced inflammation by suppressing PKCδ-STAT1 signaling.
- Comparing the Independent Effects of Weight Loss or Exercise Training on Lipid Subcellular Metabolism.
- Exercise and Insulin Resistance.
- Update on the effects of physical activity on insulin sensitivity in humans.
- Miro1 mediates skeletal muscle insulin resistance in type 2 diabetes.
- Effects of an 8-week elastic band resistance training program on hepatic steatosis, insulin resistance, and circulating irisin in postmenopausal women with MASLD: A randomized controlled trial.
Frequently Asked Questions
How does insulin resistance lead to weight gain?
When cells become resistant to insulin, the pancreas produces more of it to compensate. These elevated insulin levels, known as hyperinsulinaemia, promote fat storage, particularly visceral fat around the abdomen, making weight gain more likely.
Can improving insulin resistance help with weight loss?
Yes. Improving insulin sensitivity through dietary change, regular physical activity, and where appropriate pharmacological support can make it easier to lose weight. Even modest weight loss of 5 to 10 per cent of body weight can further improve insulin sensitivity, reinforcing the benefit.
When should I see a GP about insulin resistance and weight gain?
You should speak to your GP if you have persistent difficulty losing weight alongside signs such as central weight gain, fatigue after meals, or skin changes such as acanthosis nigricans. Seek prompt advice if you experience increased thirst, frequent urination, or unexplained weight loss, as these may indicate diabetes.
The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.
The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.
Any third-party brands or services referenced on this site are included for informational purposes only; we are entirely independent and have no affiliation, partnership, or collaboration with any companies mentioned.
